Responses
Regular and young investigator award abstracts
Immune-stimulants and immune modulators
589 Efficacy of oncolytic vaccinia virus requires infection of suppressive immune cells in the tumor microenvironment leading to their reprogramming and deletion
Compose a Response to This Article
Other responses
No responses have been published for this article.
